Therapeutic Potential of Trigonelline Nanoparticles In The Expression of IRS1 IRS2 and TNF and#593; In Type 2 Diabetic Mice

Abstract

newline

Description

Keywords

Citation

item.page.endorsement

item.page.review

item.page.supplemented

item.page.referenced